The Fertility Awareness Method and Managing Stress Urinary Incontinence (SUI), an Advanced Study

Urinary incontinence is a common problem affecting 25–45% women. Effective management can have a huge impact on a patient’s quality of life and many treatments are available. Management should be dictated by the degree of bother the symptoms are having, and vary depending on the type on incontinence. Conservative measures should always be initiated, including optimisation of body mass index and smoking cessation. Overactive bladder and urge urinary incontinence can be improved with bladder retraining and avoidance of bladder stimulants. Medical treatment then includes anticholinergic medications or Mirabegron. More invasive options include Botulinum Toxin A (Botox®) injections, sacral nerve stimulation or urological surgery. Stress urinary incontinence should be managed initially with pelvic floor exercises, and input from a specialist nurse or physiotherapist is beneficial. The surgical options for managing stress incontinence have changed considerably over the years, but include bladder neck injections, mid-urethral slings, colposuspension or autologous fascial slings. Mixed urinary incontinence is more challenging to manage, but all conservative measures should be started. Further treatment is directed towards the predominant symptom, but overactivity should be controlled before surgical measures for stress urinary incontinence are performed.

Download Full-text

Managing stress urinary incontinence

Practice Nursing ◽

10.12968/pnur.2005.16.1.17341 ◽

2005 ◽

Vol 16 (1) ◽

pp. 17-24 ◽

Cited By ~ 1

Author(s):

Kate Anders

Keyword(s):

Urinary Incontinence ◽

Stress Urinary Incontinence ◽

Managing Stress

Download Full-text

Non-Hormonal Contraceptive Device with Multiple Uses: Increases The Effectiveness of Fertility Awareness Methods and Controls Stress Incontinence

10.47363/jjcmr/2021(1)108 ◽

2021 ◽

pp. 1-6

Author(s):

Shihata Alfred ◽

◽

Brody Steven A ◽

Keyword(s):

Urinary Incontinence ◽

Stress Urinary Incontinence ◽

Cost Effective ◽

Hormonal Contraceptive ◽

Vaginal Fluid ◽

Contraceptive Device ◽

Barrier Method ◽

Pilot Studies ◽

Fertility Awareness ◽

Vaginal Anatomy

This article addresses three unmet women’s reproductive health needs, and how the FemCap can fulfill these needs. The FemCap is an FDA-approved, non-hormonal contraceptive device that can accommodate some deficient areas of women’s health: 1. A scarcity of hormone-free contraceptive methods. 2. Enhancement of fertility awareness method that is infrequently used but is the safest method. 3. Help Millions of women who suffer silently from stress urinary incontinence. The FemCap blocks sperm from entering the cervix. It is time-tested to be safe and effective for contraception. Using the FemCap directly at the cervix, it can collect the fertile cervical mucus without mixing it with any other vaginal fluid. Current pessaries used to treat stress urinary incontinence (SUI) have significant drawbacks, including displacement, erosion, ulceration, of the vagina and urethral blockage. The rim of the FemCap performs the same function as the ring pessary by supporting the bladder neck. The outward flared brim restores the urethra and vaginal anatomy. At the same time, the bowl of the FemCap keep the cervix from prolapsing further. The FemCap is a long-established barrier method of contraception, and pilot studies results show it can improve fertility awareness methods and manage Stress Urinary Incontinence. It would be ideal and cost-effective to have a single reusable device with several functions for contraceptives, increasing the acceptability and effectiveness of fertility awareness methods, and stress urinary incontinence control. The FemCap would be an ideal alternative to the condom.

Download Full-text

Contraceptive Device Discovered to Have Broad Spectrum Application for Women’s Basic Unmet Needs

Journal of Gynecology & Reproductive Medicine ◽

10.33140/jgrm.05.02.16 ◽

2021 ◽

Vol 5 (2) ◽

Keyword(s):

Urinary Incontinence ◽

Stress Urinary Incontinence ◽

Delivery System ◽

Nurse Practitioners ◽

Hormonal Contraceptive ◽

Contraceptive Device ◽

Pilot Studies ◽

Fertility Awareness ◽

Vaginal Gel ◽

Vaginal Pessary

Introduction: The FemCap is an FDA, and CE mark approved barrier contraceptive device. To our surprise, it was found to apply to several basic unmet reproductive health needs for women. a) The FemCap is time tested hormone-free contraceptive device, b) It offers an alternative delivery system to the traditional vaginal applicator, c) It provides a safe and effective non-surgical treatment for stress urinary incontinence (SUI), d) It enhances the fertility awareness methods. Methodology: We conducted several pilot studies to explore the potential of the FemCap. We compared the retention and distribution of stained vaginal gel if inserted with the FemCap versus the same amount of gel when inserted by the vaginal applicator. We compared the safety and effectiveness of the FemCap with a vaginal pessary that treats stress urinary incontinence. We collected the fertile cervical mucous (Spinnbarkeit) with the FemCap to determine the time of ovulation to enhance the fertility awareness method. Results: The FemCap is a well-established, safe, and effective non-hormonal contraceptive. The retention and distribution of stained vaginal gel inserted with the FemCap is more efficient than the vaginal applicator. The FemCap’s unique storage groove for microbicides can potentially be utilized to treat sexually transmitted infections (STIs) topically. FemCap is also found to be substantially equivalent to the incontinence pessary in controlling stress urinary incontinence (SUI). The FemCap did also help to collect fertile cervical mucous (Spinnbarkeit) when using fertility awareness methods. Conclusion: The multipurpose FemCap would be an ideal tool for nurse practitioners, midwives, and physicians to provide women with safe and effective, hormone-free contraception. It also provides an efficient delivery system for spermicide/microbicides. It is much safer for non-surgical management of stress urinary incontinence. It is useful for the enhancement of fertility awareness methods. It is non-invasive and can be inserted and removed by the woman without professional help.

Download Full-text

Ongoing Research for Managing Stress Urinary Incontinence in Women with a FDA Approved Device, The FemCap™

International Journal of Women’s Health Care ◽

10.33140/ijwhc.06.01.01 ◽

2021 ◽

Vol 6 (1) ◽

Keyword(s):

Urinary Incontinence ◽

Pilot Study ◽

Stress Urinary Incontinence ◽

Bladder Neck ◽

First Line ◽

Ongoing Research ◽

Ring Pessary ◽

Treatment And Prevention ◽

Menopausal Women ◽

Managing Stress

Background: The previous successful pilot study led the inventor to expand into Sweden and increase the number of participants. We also expanded the research comparing the FemCap to other Pessaries on the market. Pessary treatment is conservative with significant limitations. These limitations include displacement, erosion, ulceration, and urethral obstruction. Stress urinary incontinence (SUI) is prevalent particularly among menopausal women. The first line of SUI treatment is the ring pessary however, a variety of different pessaries have been introduced into the market with hope of achieving better results. Objectives: To provide women with a safer, more effective device to treat SUI. Materials and Methods: The FemCap combines the features of the ring and space- occupying pessaries into one device, which makes it more successful. The Bowl of the Dome of the FemCap covers the cervix and prevents it from prolapsing. The Rim fits snugly into the vaginal fornices that supports the bladder neck. The Brim flares outward pushing against the cystocele and urethrocele anteriorly to restore the anatomy of the urethra and the bladder. We recruited 118 women who had significant SUI and asked them to compare their experience for one week before using the FemCap and one week after. The FemCap was self-inserted and removed by the participants. Results: Only 100 women completed the study 94 were completely dry after one week, while 6 women were not satisfied with the results. No side effects were reported by the participants and pelvic examinations did not show any erosion or ulceration of the vagina. Conclusion: The FemCap is safe and effective in restoring the anatomy of the bladder, and urethra, which could make it ideal for the treatment and prevention of mild to moderate SUI. More studies are warranted to further prove the utility of the FemCap to manage SUI.

Download Full-text